| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Treatment of Anxiety: Targeting Glutamate
|
Simon, Asher B.
|
|
2006
|
3 |
1 |
p. 57-68
12 p.
|
artikel
|
| 2 |
Advances in the treatment of anxiety: Targeting glutamate
|
Simon, Asher B.
|
|
2006
|
3 |
1 |
p. 57-68
|
artikel
|
| 3 |
Advances in the Treatment of Depression
|
Holtzheimer III, Paul E.
|
|
2006
|
3 |
1 |
p. 42-56
15 p.
|
artikel
|
| 4 |
Advances in the treatment of depression
|
Holtzheimer, Paul E.
|
|
2006
|
3 |
1 |
p. 42-56
|
artikel
|
| 5 |
Catechol-O-Methyltransferase Polymorphisms and Some Implications for Cognitive Therapeutics
|
Diaz-Asper, Catherine M.
|
|
2006
|
3 |
1 |
p. 97-105
9 p.
|
artikel
|
| 6 |
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics
|
Diaz-Asper, Catherine M.
|
|
2006
|
3 |
1 |
p. 97-105
|
artikel
|
| 7 |
Finding what you are not looking for: Strategies for developing novel treatments in psychiatry
|
Stahl, Stephen M.
|
|
2006
|
3 |
1 |
p. 3-9
|
artikel
|
| 8 |
Finding What You Are Not Looking for: Strategies for Developing Novel Treatments in Psychiatry
|
Stahl, Stephen M.
|
|
2006
|
3 |
1 |
p. 3-9
7 p.
|
artikel
|
| 9 |
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder
|
Pittenger, Christopher
|
|
2006
|
3 |
1 |
p. 69-81
|
artikel
|
| 10 |
Glutamate-Modulating Drugs as Novel Pharmacotherapeutic Agents in the Treatment of Obsessive-Compulsive Disorder
|
Pittenger, Christopher
|
|
2006
|
3 |
1 |
p. 69-81
13 p.
|
artikel
|
| 11 |
How Antipsychotics Work—From Receptors to Reality
|
Kapur, Shitij
|
|
2006
|
3 |
1 |
p. 10-21
12 p.
|
artikel
|
| 12 |
How antipsychotics work—From receptors to reality
|
Kapur, Shitij
|
|
2006
|
3 |
1 |
p. 10-21
|
artikel
|
| 13 |
Imaging Genomics and Response to Treatment with Antipsychotics in Schizophrenia
|
Blasi, Giuseppe
|
|
2006
|
3 |
1 |
p. 117-130
14 p.
|
artikel
|
| 14 |
Imaging genomics and response to treatment with antipsychotics in schizophrenia
|
Blasi, Giuseppe
|
|
2006
|
3 |
1 |
p. 117-130
|
artikel
|
| 15 |
Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets
|
Carlson, Paul J.
|
|
2006
|
3 |
1 |
p. 22-41
|
artikel
|
| 16 |
Neural Circuitry and Neuroplasticity in Mood Disorders: Insights for Novel Therapeutic Targets
|
Carlson, Paul J.
|
|
2006
|
3 |
1 |
p. 22-41
20 p.
|
artikel
|
| 17 |
New directions in psychiatric therapeutics
|
Weinberger, Daniel R.
|
|
2006
|
3 |
1 |
p. 1-2
|
artikel
|
| 18 |
New Directions in Psychiatric Therapeutics
|
Weinberger, Daniel R.
|
|
2006
|
3 |
1 |
p. 1-2
2 p.
|
artikel
|
| 19 |
Pharmacogenetic Tools for the Development of Target-Oriented Cognitive-Enhancing Drugs
|
Apud, José A.
|
|
2006
|
3 |
1 |
p. 106-116
11 p.
|
artikel
|
| 20 |
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs
|
Apud, José A.
|
|
2006
|
3 |
1 |
p. 106-116
|
artikel
|
| 21 |
Pharmacological Treatments that Facilitate Extinction of Fear: Relevance to Psychotherapy
|
Davis, Michael
|
|
2006
|
3 |
1 |
p. 82-96
15 p.
|
artikel
|
| 22 |
Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy
|
Davis, Michael
|
|
2006
|
3 |
1 |
p. 82-96
|
artikel
|
Tijdschrift beschrijving